EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity

Sara Darbandi iD, Alfonso Urbanucci, Sini Hakkola, Juanita Gujral, Mahsa Darbandi, Ahmed Eraky iD, Sujit Nair, Goutam Chakraborty, Ashutosh Tewari, Natasha Kyprianou

The Prostate · 2026

DOI: 10.1002/pros.70139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Prostate, 2026. Verfasst von Sara Darbandi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Ion Channels, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 142 Literaturangaben. Gefördert von: NIH/NCI grants, TJ Martell Foundation, and international agencies including the Norwegian Cancer Society, Research Council of Finland, Tampere Institute (AU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plasticity of cancer, including epithelial–mesenchymal transition (EMT), cancer stem cell (CSC) self‐renewal, and microenvironmental adaptation, drives metastasis, therapy resistance, and poor outcomes in prostate cancer (PCa). Ion channels and extrachromosomal DNA (ecDNA) have emerged as key drivers of such adaptive processes by influencing signaling, metabolism, and immune interactions.

Methods

We evaluated available evidence on ion channel biology, ecDNA dynamics, and their roles in tumor plasticity and drug resistance in PCa. Further, we analyzed two publicly accessible single‐cell RNA‐sequencing (scRNA‐seq) datasets (primary PCa and castration‐resistant PCa) to determine ion channel and transporter expression profiles in tumor and stromal cell populations.

Results

Our analysis showed cell type–specific expression of many ion channels, including KCNJ10, CACNA1H, and CLIC1, and identification of six transporters (SLC25A1, SLC25A10, SLC25A33, SLC25A42, SLC29A2, SLC7A11) strongly enriched in luminal tumor cells. The discovered genes regulate mitochondrial metabolism, redox homeostasis, nucleotide biosynthesis, immune modulation, and resistance to ferroptosis, all contributing to tumor growth. ecDNA facilitates oncogene amplification (e.g., MYC, EGFR), induction of EMT, and immune evasion, driving intratumoral heterogeneity and therapy‐resistant clones.

Conclusions

Ion channels and ecDNA are central to the disease progression and treatment resistance of PCa through regulation of EMT, CSC phenotype, and tumor microenvironment (TME) interactions. Targeting the drivers—through ion channel modulators, ferroptosis induction, and ecDNA‐targeting interventions (BET/HDAC inhibitors, CRISPR‐based methods) offers a promising way to overcome resistance. Integration of multi‐omics, and combination treatments will be key to construct precision medicine strategies and improve clinical outcomes in advanced PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentIon ChannelsProstatic NeoplasmsHumansMaleExtrachromosomal DNAEpithelial-Mesenchymal TransitionNeoplastic Stem CellsDrug Resistance, NeoplasmPhenotype

Stichwörter der Autor:innen

Epithelial‐Mesenchymal Transition (EMT)Ion ChannelsMesenchymal‐Epithelial Transition (MET)MetastasisMicroenvironmentPhenotypic LandscapeProstate CancerTherapeutic TargetingTumor Recurrence

Substanzen

Extrachromosomal DNAIon Channels

Autor:innen und Institutionen

  • Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Center for Cancer Eradication Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Finland Tampere University, Tampere, Finland.
  • Finnish Cancer Institute.
  • Department of Oncological Sciences, Tisch Cancer Institute, New York, USA.
  • Department of Pathology & Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

ORCID-Profile: Sara Darbandi, Ahmed Eraky

Förderung

  • NIH/NCI grants
  • TJ Martell Foundation, and international agencies including the Norwegian Cancer Society
  • Research Council of Finland, Tampere Institute (AU)
  • the Finnish Cultural Foundation/Center of Excellence in Tumour Genetics Research
  • The Arthur M. Blank Family Foundation (AKT)

Zitieren

APA

Darbandi, S., Urbanucci, A., Hakkola, S., Gujral, J., Darbandi, M., Eraky, A., Nair, S., Chakraborty, G., Tewari, A., & Kyprianou, N. (2026). Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity. The Prostate. https://doi.org/10.1002/pros.70139

Vancouver

Darbandi S, Urbanucci A, Hakkola S, Gujral J, Darbandi M, Eraky A, et al. Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity. The Prostate. 2026. doi:10.1002/pros.70139

BibTeX
@article{Darbandi2026,
  author = {Darbandi, Sara and Urbanucci, Alfonso and Hakkola, Sini and Gujral, Juanita and Darbandi, Mahsa and Eraky, Ahmed and Nair, Sujit and Chakraborty, Goutam and Tewari, Ashutosh and Kyprianou, Natasha},
  title = {Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70139}
}
Kostenlos starten →